R. Volckmann

Research output

Research output per year 2007 2012 2022 2023

• 29 Article
• 2 Comment/Letter to the editor

Research output per year

Research output per year

Search results

• 2022

  Erratum: Mesenchymal-Type Neuroblastoma Cells Escape ALK Inhibitors (Cancer Res (2022) 82 (484–496) DOI: 10.1158/0008-5472.CAN-21-1621)

  Westerhout, E. M., Hamdi, M., Stroeken, P., Nowakowska, N. E., Lakeman, A., van Arkel, J., Hasselt, N. E., Blejlevens, B., Akogul, N., Haneveld, F., Chan, A., van Sluis, P., Zwijnenburg, D., Volckmann, R., van Noesel, C. J. M., Adameyko, I., van Gronigen, T., Koster, J., Valentijn, L. J., van Nes, J., & 1 othersVersteeg, R., 15 Jul 2022, In: Cancer research. 82, 14, p. 2657 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
• 2020

  Author Correction: c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (Nature Immunology, (2019), 20, 8, (992-1003), 10.1038/s41590-019-0423-0)

  Bernink, J. H., Ohne, Y., Teunissen, M. B. M., Wang, J., Wu, J., Krabbendam, L., Guntermann, C., Volckmann, R., Koster, J., van Tol, S., Ramirez, I., Shrestha, Y., de Rie, M. A., Spits, H., Ros, X. R. & Humbles, A. A., 1 Jan 2020, In: Nature immunology. 21, 1, p. 101 1 p.

  Research output: Contribution to journal › Comment/Letter to the editor › Academic

  Open Access
  1 Citation (Scopus)